Teva recalls
11 federal recalls on file, showing the 9 from the last 12 months. We read every CPSC, FDA, USDA and NHTSA notice for Teva and put it in plain English.
Recent recalls
Teva metoclopramide tablets recalled for foreign tablets or capsulesTeva Pharmaceuticals discovered that some bottles of Metoclopramide 5 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The contamination was found in specific lots distributed nationwide. No injuries have been reported.
ModerateFDAOct 21, 2026
- Teva trazodone 50 mg recalled for foreign tablets
Teva Pharmaceuticals discovered that some bottles of trazodone 50 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The issue affects one lot (1394026) with an expiration date of February 2028. No injuries have been reported.
ModerateFDASep 9, 2026
- Teva Claravis isotretinoin capsules recalled for impurity levels
Teva Pharmaceuticals is recalling specific lots of Claravis (isotretinoin) 10 mg capsules because they contain higher-than-allowed levels of tretinoin, a related chemical impurity. The affected lots are 100067507 and 100067508, which expire on July 31, 2026. No injuries have been reported so far.
ModerateFDAApr 29, 2026
- Teva clonidine patches recalled for unapproved raw material
Teva Pharmaceuticals is recalling certain Clonidine Transdermal System patches (0.1 mg/day) because they were manufactured using an unapproved raw material that does not meet FDA standards. The affected patches were distributed in the U.S. The company and FDA are working to ensure the product is removed from use.
ModerateFDAApr 15, 20263 products
- Teva isotretinoin capsules recalled for potency errors
Teva is recalling two strengths of isotretinoin capsules, 30 mg and 40 mg, because some capsules may be stronger or weaker than the labeled amount. The recall covers 10-count prescription packs distributed in Florida, Ohio, Puerto Rico and Mississippi, and no injuries have been reported.
ModerateFDAApr 15, 20262 products
- Stop using Teva Octreotide Acetate injection
Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate injectable suspension due to sterility concerns identified at the manufacturing facility. The FDA found quality system deficiencies that could affect the safety of the medication.
ModerateFDAApr 1, 20263 products
- Teva metoprolol succinate tablets recalled for dissolution failure
Teva is recalling four strengths of metoprolol succinate extended-release tablets (25 mg, 50 mg, 100 mg and 200 mg), sold in 100- and 1,000-tablet bottles. The tablets did not meet the required dissolution specification, which means they may not release the medicine at the expected rate. No injuries have been reported.
ModerateFDAMar 11, 20264 products
- Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.
Defective Container - A defect in the side-seal which allows leakage of product.
FDADec 10, 2025
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Subpotent drug; Clavulanate Potassium component
FDANov 12, 2025